scholarly article | Q13442814 |
P2093 | author name string | Praveen Sharma | |
Barjesh Chander Sharma | |||
P2860 | cites work | Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. | Q31034988 |
Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction | Q33600116 | ||
Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. | Q34116455 | ||
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy | Q34576485 | ||
Extrahepatic portal vein obstruction | Q34584415 | ||
Consensus on extra-hepatic portal vein obstruction | Q36500591 | ||
Gastrointestinal bleeding in children | Q39435347 | ||
Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. | Q39994341 | ||
Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. | Q43172827 | ||
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy | Q43746145 | ||
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction | Q44974056 | ||
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy | Q46604042 | ||
Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation | Q48265752 | ||
Critical flicker frequency for quantification of low-grade hepatic encephalopathy. | Q51960052 | ||
Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy | Q73009209 | ||
Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis | Q73876935 | ||
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy | Q73939817 | ||
The prognostic significance of subclinical hepatic encephalopathy | Q74194609 | ||
Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests | Q77807943 | ||
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy | Q80060307 | ||
Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy | Q80217595 | ||
Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations | Q80639802 | ||
Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction | Q81355219 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | β-lactulose | Q422689 |
hepatic encephalopathy | Q642548 | ||
P304 | page(s) | 168-172 | |
P577 | publication date | 2012-05-01 | |
P1433 | published in | Saudi Journal of Gastroenterology | Q15817344 |
P1476 | title | Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction | |
P478 | volume | 18 |
Q47624674 | A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction |
Q36945543 | A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy |
Q37139141 | Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy |
Q38086120 | Disaccharides in the treatment of hepatic encephalopathy |
Q38515281 | Management of covert hepatic encephalopathy |
Q49082130 | Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy |
Q87431760 | Treatment options for covert hepatic encephalopathy |
Q36020911 | What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides? |